Skin Diseases  >>  albumin-bound paclitaxel  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
albumin-bound paclitaxel / Generic mfg.
NCT00308178: Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer

Completed
N/A
66
US
Abraxane
Harold J. Burstein, MD, PhD, Celgene Corporation, Beth Israel Deaconess Medical Center, Massachusetts General Hospital
Breast Cancer
09/06
06/08
TRIBECA, NCT02064829: Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer

Completed
N/A
111
US, Europe, RoW
Nab-paclitaxel, Paclitaxel albumin-bound particles for injectable suspension, IG-001, Paclitaxel polymeric micelles for injectable suspension, Genexol-PM, Cynviloq
Sorrento Therapeutics, Inc.
Metastatic Breast Cancer, Locally Recurrent Breast Cancer
02/15
07/15
Nabucco, NCT01689610: Non-interventional Study With Nab-Paclitaxel (Abraxane®)

Completed
N/A
705
Europe
iOMEDICO AG
Metastatic Breast Cancer
11/15
03/16

Download Options